CytomX

CytomX is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases. Read more

Sean A. McCarthy's photo - Chairman & CEO of CytomX

Chairman & CEO

Sean A. McCarthy

CEO Approval Rating

91/100

Founded:

2008

Status:

PublicIndependent CompanyNASDAQCTMX

CYTOMX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ADC Therapeutics is one of CytomX's top competitors. ADC Therapeutics was founded in 2011, and its headquarters is in Epalinges, Vaud. Like CytomX, ADC Therapeutics also works within the Biotechnology sector. ADC Therapeutics has 71 more employees than CytomX.

ADC Bio is CytomX's #2 rival. ADC Bio was founded in 2010 in Chester, England. ADC Bio operates in the Biotechnology industry. ADC Bio generates $62.7M less revenue than CytomX.

Meditope is a top competitor of CytomX. Meditope is a Private company that was founded in Pasadena, California in 2011. Meditope is in the Biotechnology field. Meditope has 97 fewer employees vs. CytomX.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is ImmunGene a competitor of CytomX?

CytomX Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$66.7M

CytomX's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 1.3B. Over the last four quarters, CytomX's revenue has decreased by 3.8%. Specifically, in Q1 2021's revenue was $16M; in Q4 2020, it was $16.4M; in Q3 2020, it was $17.8M; in Q2 2020, CytomX's revenue was $16.6M.

CytomX Acquisitions

No recent acquisitions found related to CytomX

CytomX Funding History

Since CytomX was founded in 2008, it has participated in 11 rounds of funding. In total CytomX has raised $197.0M. CytomX's last funding round was on Oct 2015 for a total of $80.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Oct 2015
$80M
-
Series D
Jun 2015
$70M

Deerfield Management

Series C
Feb 2015
$1.5M
-
Series C
Dec 2014
$16.5M
Equity
Jul 2012
$12.6M
-

Since CytomX was founded in 2008, it has participated in 11 rounds of funding. In total CytomX has raised $197.0M. CytomX's last funding round was on Oct 2015 for a total of $80.0M

CytomX Investments

No recent investments found related to CytomX

CytomX News

January 26, 2021BioSpace

CytomX Therapeutics Announces Closing of Public Offering of Common Stock

CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company... See more »
January 21, 2021BioSpace

CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock - Jan 21, 2021

CytomX Therapeutics, Inc., a clinical-stage, oncology-focused biopharmaceutical company with a vision... See more »
January 19, 2021BioSpace

CytomX Therapeutics Announces New Employment Inducement Grants - Jan 19, 2021

CytomX Therapeutics, Inc. announced that on January 15, 2021, the Company granted two new employees o... See more »
January 14, 2021MarketScreener

39th Annual J.P. Morgan Health Care Conference

(marketscreener.com) 39th Annual J.P. Morgan Healthcare Conference Sean McCarthy, D.Phil. President, ... See more »
January 7, 2021Benzinga

CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX... See more »
December 22, 2020Micro Small Cap

CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) - CytomX Therapeutics, Inc. (Nasdaq: CTMX... See more »

CytomX Press Releases

February 22, 2021GlobeNewswire

CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTM... See more »
February 19, 2021GlobalNewswire

CytomX Therapeutics Announces New Employment Inducement Grant

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTM... See more »
February 17, 2021GlobeNewswire

CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTM... See more »
February 4, 2021GlobeNewswire

CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTM... See more »
November 12, 2020GlobeNewswire

CytomX Therapeutics to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTM... See more »
November 5, 2020GlobeNewswire

CytomX Therapeutics Announces Treatment of First Patient in Phase 2 Expansion Study of CX-2029, an Anti-CD71 Probody Drug Conjugate

- Advancement Follows ASCO 2020 Data Validating CD71 as an Anti-Cancer Target and Supporting Phase 2 ... See more »

CytomX Videos

Social Media

CytomX Headquarters

151 Oyster Point Boulevard Suite 400

South San Francisco, California94080

650-515-3185

Driving Directions »

Trending Companies

CytomX Summary

ABOUT

Overview

CytomX is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases. CytomX was founded in 2008. CytomX's headquarters is located in South San Francisco, California, USA 94080....

CEO

CytomX's Chairman & CEO, Sean A. McCarthy, currently has an approval rating of 91%. CytomX's primary competitors are ADC Therapeutics, ADC Bio & Meditope.

Website

cytomx.com

Frequently Asked Questions about CytomX

  1. When was CytomX founded?

    CytomX was founded in 2008
  2. Who is CytomX's CEO?

    CytomX's CEO is Sean A. McCarthy
  3. How much revenue does CytomX generate?

    CytomX generates $66.7M in revenue
  4. How much funding does CytomX have?

    CytomX has historically raised $197M in funding
  1. Where is CytomX's headquarters?

    CytomX's headquarters is in South San Francisco California, USA
  2. How many employees does CytomX have?

    CytomX has 137 employees
  3. What sector does CytomX operate in?

    CytomX is in Biotechnology, Pharmaceuticals
  4. Who are CytomX's competitors?

    CytomX's top competitors are ADC Therapeutics, ADC Bio, Meditope